AarogyaAI

AarogyaAI Innovations Pvt.

Ltd. is a health technology startup based in Bengaluru, India, founded in 2019. The company focuses on leveraging artificial intelligence and genomics to provide rapid, precision diagnostics for antimicrobial resistance, particularly drug-resistant tuberculosis (DR-TB). Their core product, AAICare, is an AI-enabled software that delivers drug susceptibility reports in just a few hours, significantly faster than traditional methods. AarogyaAI aims to make precision diagnostics accessible at the point of care, empowering healthcare professionals with data-driven insights. Their platform supports clinicians with an analytics dashboard for effective treatment decisions and is designed to function across various devices. The company primarily serves diagnostic labs, hospitals, public health programs, and pharmaceutical companies, with plans to expand its diagnostic capabilities to other antimicrobial diseases in the future. AarogyaAI is committed to addressing healthcare challenges in South Asia and making its tests available in remote areas at affordable prices.